DeFord John A — SEC insider filings
SEC reporting owner CIK 1403373. 33 insider filings on record with FilingPulse; latest filed 2026-11-03.
Transaction summary — filings shown
Covers all 33 filings on record, filed 2020-11-25 to 2026-11-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 17,500 shares, $100,625 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 44.
- Largest priced transaction: purchase of 17,500 shares @ $5.75 ($100,625) in MARAVAI LIFESCIENCES HOLDINGS, INC., filed 2024-11-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) | Director | 5 | 1 leg · 17,500 sh · $100,625 | — | 4 |
| NORDSON CORP (NDSN) | Director | 19 | — | — | 23 |
| NUVASIVE INC (NUVA) | Director | 4 | — | — | 10 |
| GLOBUS MEDICAL INC (GMED) | Director | 5 | — | — | 7 |
Insider filings — DeFord John A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-03 | 4 | NORDSON CORP (NDSN) | Grant/award (A): 77 @ $322.67 · Grant/award (A): 583 @ $322.67 | EDGAR |
| 2026-08-03 | 4 | NORDSON CORP (NDSN) | Grant/award (A): 84 @ $297.78 | EDGAR |
| 2026-05-28 | 4 | MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) | Grant/award (A): 46,293 @ $0 | EDGAR |
| 2026-05-04 | 4 | NORDSON CORP (NDSN) | Grant/award (A): 87 @ $288.45 | EDGAR |
| 2026-02-03 | 4 | NORDSON CORP (NDSN) | Grant/award (A): 91 @ $274.53 | EDGAR |
| 2026-01-23 | 4 | GLOBUS MEDICAL INC (GMED) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-11-03 | 4 | NORDSON CORP (NDSN) | Grant/award (A): 822 @ $231.95 | EDGAR |
| 2025-06-18 | 4 | MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) | Grant/award (A): 89,139 @ $2.16 | EDGAR |
| 2025-03-28 | 4 | GLOBUS MEDICAL INC (GMED) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-11-14 | 4 | MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) | Purchase (P): 17,500 @ $5.75 | EDGAR |
| 2024-11-04 | 4 | NORDSON CORP (NDSN) | Grant/award (A): 747 @ $249.03 | EDGAR |
| 2024-05-24 | 4 | MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) | Grant/award (A): 20,645 @ $10.78 | EDGAR |
| 2024-01-30 | 4 | GLOBUS MEDICAL INC (GMED) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2023-11-02 | 4 | NORDSON CORP (NDSN) | Grant/award (A): 105 @ $212.59 · Grant/award (A): 749 @ $211.52 | EDGAR |
| 2023-09-06 | 4/A | GLOBUS MEDICAL INC (GMED) | Grant/award (A): 15,578 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2023-09-06 | 4 | GLOBUS MEDICAL INC (GMED) | Grant/award (A): 15,578 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2023-09-05 | 4 | NUVASIVE INC (NUVA) | Disposition to issuer (D): 563 (derivative) @ $0 · Disposition to issuer (D): 3,230 (derivative) @ $0 · Disposition to issuer (D): 2,577 (derivative) @ $0 · Disposition to issuer (D): 3,095 (derivative) @ $0 · Disposition to issuer (D): 2,702 (derivative) @ $0 · Disposition to issuer (D): 3,788 (derivative) @ $0 · +1 more | EDGAR |
| 2023-08-01 | 4 | NORDSON CORP (NDSN) | Grant/award (A): 89 @ $251.61 | EDGAR |
| 2023-07-21 | 4 | MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) | Grant/award (A): 31,901 @ $0 | EDGAR |
| 2023-06-12 | 4 | NUVASIVE INC (NUVA) | Grant/award (A): 4,816 (derivative) @ $0 | EDGAR |
| 2023-05-02 | 4 | NORDSON CORP (NDSN) | Grant/award (A): 104 @ $216.31 | EDGAR |
| 2023-02-02 | 4 | NORDSON CORP (NDSN) | Grant/award (A): 92 @ $243.30 | EDGAR |
| 2022-11-02 | 4 | NORDSON CORP (NDSN) | Grant/award (A): 100 @ $225 · Grant/award (A): 730 @ $225.93 | EDGAR |
| 2022-08-02 | 4 | NORDSON CORP (NDSN) | Grant/award (A): 97 @ $230.99 | EDGAR |
| 2022-05-13 | 4 | NUVASIVE INC (NUVA) | Grant/award (A): 3,788 (derivative) @ $0 | EDGAR |
| 2022-05-02 | 4 | NORDSON CORP (NDSN) | Grant/award (A): 104 @ $215.69 | EDGAR |
| 2022-02-01 | 4 | NORDSON CORP (NDSN) | Grant/award (A): 96 @ $232.54 | EDGAR |
| 2021-11-02 | 4 | NORDSON CORP (NDSN) | Grant/award (A): 79 @ $254.21 · Grant/award (A): 608 @ $238.43 | EDGAR |
| 2021-08-03 | 4 | NORDSON CORP (NDSN) | Grant/award (A): 88 @ $226.13 | EDGAR |
| 2021-05-20 | 4 | NUVASIVE INC (NUVA) | Grant/award (A): 2,702 (derivative) @ $0 | EDGAR |
| 2021-05-04 | 4 | NORDSON CORP (NDSN) | Grant/award (A): 94 @ $211.41 | EDGAR |
| 2021-02-02 | 4 | NORDSON CORP (NDSN) | Grant/award (A): 85 @ $178.99 | EDGAR |
| 2020-11-25 | 4 | NORDSON CORP (NDSN) | Grant/award (A): 622 @ $196.27 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1403373 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs